Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Journal:
Current Proteomics
Volume:
2
Page:
83-86
Author(s):
Sean R. Gallagher
NO News is not Necessarily Good News in Cancer
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
103-115
Author(s):
Suhendan Ekmekcioglu, Chi-Hui Tang and Elizabeth A. Grimm
Graphical Abstracts
Journal:
Letters in Drug Design & Discovery
Volume:
2
Page:
v-v
Author(s):
Tamarind Inhibits Solar-Simulated Ultraviolet Radiation-Induced Suppression of Recall Responses in Humans
Journal:
Letters in Drug Design & Discovery
Volume:
2
Page:
165-171
Author(s):
J. M. Kuchel, R. St. C. Barnetson, L. Zhuang, F. M. Strickland, R. P. Pelley and G. M. Halliday
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
115-130
Author(s):
Mohanraj Dhanabal, Mike Jeffers and William J. LaRochelle
Subject Index to Volume 4
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
73-84
Author(s):
Bentham Science Publishers
Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
581-611
Author(s):
Sander W. Tas, Philip H.J. Remans, Kris A. Reedquist and Paul P. Tak
Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
85-99
Author(s):
Francesco Di Virgilio, O. Roberto Baricordi, Romeo Romagnoli and Pier Giovanni Baraldi
Subject Index to Volume 10
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
101-142
Author(s):
Bentham Science Publishers
Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
4081-4101
Author(s):
Veronic Marie Isabelle Provencher, Ersilia Coccaro, Jonathan Jacques Lacasse and Luis Maria Schang